| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/02/2006 | US20060246415 Methods for detection of breast cancer |
| 11/02/2006 | US20060246125 Proteoliposome for use as gene transfer tool in treatment and diagnosis of cardiomyopathy, type II diabetes, Alzheimer's, Parkinson's diseases; gene therapy |
| 11/02/2006 | US20060246123 Oligonucleotide mimetics |
| 11/02/2006 | US20060246065 Fail molecules and uses thereof |
| 11/02/2006 | US20060246059 therapeutic protein comprising a tenth domain of fibronectin type III; protein scaffold; antibody design; scaffold derived from a fibronectin type III (Fn3) or Fn3-like domain, function like natural or engineered antibodies; antibody mimics designed for optimal folding, stability, and solubility |
| 11/02/2006 | US20060246052 Means for stabilization of thrombin and compositions |
| 11/02/2006 | US20060246051 Male reproductive disorders including proliferative disorders of testes |
| 11/02/2006 | US20060246048 Elongation of fatty acids(ELF) polypeptides and carrier mixtures administered for prophylaxis of vision defects |
| 11/02/2006 | US20060246028 Di-glycosil glyceryl compounds for the stabilisation and preservation of biomaterials |
| 11/02/2006 | US20060243969 Electrical detection of selected species |
| 11/02/2006 | US20060243591 Electrochemical-based analytical test strip with hydrophilicity enhanced metal electrodes |
| 11/02/2006 | EP1717587A1 Method and kit for identifying the function of gene product and identifying binding substance |
| 11/02/2006 | EP1717583A2 Cell migration assay |
| 11/02/2006 | EP1717323A2 Infectious etiologic agent detection probe and probe set, carrier, and genetic screening method |
| 11/02/2006 | EP1717322A2 Evolution of whole cells and organisms by recursive sequence recombination |
| 11/02/2006 | EP1717321A1 System for surface identification of commercial products using DNA tracer |
| 11/02/2006 | EP1717320A1 Identification of human gene sequences of cancer antigens expressed in metastatic carcinoma and involved in metastasis formation, and their use in cancer diagnosis, prognosis and therapy |
| 11/02/2006 | EP1717319A2 Method for manufacturing an electrochemical-based analytical test strip with hydrophilicity enhanced metal electrodes |
| 11/02/2006 | EP1717316A1 Interferon-like protein ZCYTO21 |
| 11/02/2006 | EP1717313A1 Nucleic acid probe, nucleic acid chip, method of detecting target nucleic acid, method of screening drug, apparatus for detecting target nucleic acid and gene diagnosis method |
| 11/02/2006 | EP1717312A1 Dna array for analyzing dna methylation, method of constructing the same and mehtod of analyzing dna methylaion |
| 11/02/2006 | EP1717249A1 Peptides containing a cholesterol recognition sequence and their uses |
| 11/02/2006 | EP1716925A2 Dispenser and method for producing DNA chip |
| 11/02/2006 | EP1716861A2 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 11/02/2006 | EP1716858A2 Oncolytic virus |
| 11/02/2006 | EP1716752A1 MyoD88-knockout mouse as a model animal unresponsive to bacterial cell wall components |
| 11/02/2006 | EP1716257A1 New primers and probes for the detection of parvovirus b19 |
| 11/02/2006 | EP1716256A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 11/02/2006 | EP1716255A2 A polynucleotide associated with a colon cancer comprising single nucleotide polymorphism, microarray and diagnostic kit comprising the same and method for diagnosing a colon cancer using the polynucleotide |
| 11/02/2006 | EP1716254A2 Methods and kits for analyzing polynucleotide sequences |
| 11/02/2006 | EP1716253A2 Gene profiling of human embryonic stem cells |
| 11/02/2006 | EP1716252A1 Detection of biologically active compounds |
| 11/02/2006 | EP1716251A1 Arrayed polynucleotides |
| 11/02/2006 | EP1716250A2 Determination of hepatitis c virus genotype |
| 11/02/2006 | EP1716249A2 Quantitative amplification and detection of small numbers of target polynucleotides |
| 11/02/2006 | EP1716248A1 Diagnostics and therapeutics for diseases associated with kallikrein 7 (klk7) |
| 11/02/2006 | EP1716247A1 Diagnostics and therapeutics for diseases associated with tripeptidyl-peptidase 2 (tpp2) |
| 11/02/2006 | EP1716246A2 Method for testing or screening for an enzyme of interest |
| 11/02/2006 | EP1716245A2 High throughput screening methods for lubricating oil compositions |
| 11/02/2006 | EP1716243A1 Process for large scale production of plasmid dna by e coli fermentation |
| 11/02/2006 | EP1716237A1 Orotate transporter encoding marker genes |
| 11/02/2006 | EP1716233A1 Regulated stop codon readthrough |
| 11/02/2006 | EP1716176A2 Cd38 splice variants and uses thereof |
| 11/02/2006 | EP1716175A2 Protein ligands for nkg2d and ul16 receptors and uses thereof |
| 11/02/2006 | EP1716171A1 IDENTIFICATION OF SNPs ASSOCIATED WITH HYPERLIPIDEMIA, DYSLIPIDEMIA AND DEFECTIVE CARBOHYDRATE METABOLISM |
| 11/02/2006 | EP1716170A2 Hyphal growth in fungi |
| 11/02/2006 | EP1716164A1 Targeted delivery of rna interference molecules for the treatment of ige-mediated disorders |
| 11/02/2006 | EP1715954A1 Multi-step bioassays on modular microfluidic application platforms |
| 11/02/2006 | EP1715870A1 Inhibition of protein kinase c-related kinase (prk) as a treatment for cardiac hypertrophy and heart failure |
| 11/02/2006 | EP1715736A2 Polypeptides having xylanase activity and polynucleotides encoding same |
| 11/02/2006 | EP1651957A4 Fluorescent magnetic nanoparticles and process of preparation |
| 11/02/2006 | EP1597383A4 Variants of cytochrome c and methods of diagnosis of thrombocytopenia |
| 11/02/2006 | EP1578723A4 Process for the preparation of oxazolidinones and method of use thereof |
| 11/02/2006 | EP1549759A4 Bacterial test method by glycated label binding |
| 11/02/2006 | EP1412758B1 Protein arrays, methods for their preparation and methods for the detection of intermolecular interactions |
| 11/02/2006 | EP1317539B1 Directed evolution method |
| 11/02/2006 | EP1311858B1 Affinity selected signature peptides for protein identification and quantification |
| 11/02/2006 | EP1309922B1 System and method for characterising and sequencing polymers |
| 11/02/2006 | EP1276760B1 Polyamide nucleic acid derivatives, agents and methods for producing them |
| 11/02/2006 | EP1105525B1 A process for preparing peptide nucleic acid probe using polymeric photoacid generator |
| 11/02/2006 | EP1051509B1 Use of indolamine derivatives for detecting micro-organism peptidase |
| 11/02/2006 | EP1038939B1 Chemiluminescent reagents and chemiluminescence analysis methods with the use of the same |
| 11/02/2006 | EP1019543B1 Method for identifying a nucleic acid |
| 11/02/2006 | EP1003874B1 Neisseria lactoferrin binding protein |
| 11/02/2006 | EP0854722B1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods |
| 11/02/2006 | EP0830591B1 Method and device for molecular sequencing |
| 11/02/2006 | EP0784695B1 Method for preparing nucleic acids for analysis and kits useful therefor |
| 11/02/2006 | DE102006021267A1 Glucocorticoid receptor ligand transactivation and transrepression activity characterizing method for primary immune cell, involves verifying regulation of expression of gene for determining transrepression and transactivation of ligand |
| 11/02/2006 | DE102005019653A1 Pflanzenextrakte gegen Halitosis, Gingivitis oder Parodontitis Plant extracts against halitosis, gingivitis or periodontitis |
| 11/02/2006 | DE102005018337A1 Mikrooptisches Detektionssystem und Verfahren zur Bestimmung temperaturabhängiger Parameter von Analyten Micro-optical detection system and method for the determination of temperature-dependent parameters of analytes |
| 11/02/2006 | CA2607468A1 Compositions for use in identification of bacteria |
| 11/02/2006 | CA2606424A1 Methods of predicting methotrexate efficacy and toxicity |
| 11/02/2006 | CA2606228A1 Methods and compositions for using alveolar macrophage phospholipase a2 |
| 11/02/2006 | CA2606194A1 Markers associated with the therapeutic efficacy of glatiramer acetate |
| 11/02/2006 | CA2606083A1 Method for evaluating compound using barlp and substance for regulating eating and body weight |
| 11/02/2006 | CA2606002A1 Multiple-rnai expression cassettes for simultaneous delivery of rnai agents related to heterozygotic expression patterns |
| 11/02/2006 | CA2605561A1 Methods using scnc3 gene mutations for spinocerebellar ataxia 13 (sca13) |
| 11/02/2006 | CA2605422A1 Evaluating bacterial lethality of containerized food production |
| 11/02/2006 | CA2605417A1 The 1,5-anhydroglucitol (1,5-ag) assay and a1c/1,5-ag assay combination for measuring blood glucose excursions in general and postprandial hyperglycemia in diabetic patients |
| 11/02/2006 | CA2605003A1 Method and system for absolute platelet percent aggregation determination |
| 11/02/2006 | CA2604761A1 Real-time hpv pcr assays |
| 11/02/2006 | CA2604692A1 Fluorescent multiplex hpv pcr assays |
| 11/01/2006 | CN2833588Y Bacterial activity comparator |
| 11/01/2006 | CN2833579Y Real-time fluorescence quantitative gene amplification instrument detection system |
| 11/01/2006 | CN1856792A Method for determination of metabolic flux affecting production of useful material |
| 11/01/2006 | CN1856710A Method for detecting procoagulant phospholipid |
| 11/01/2006 | CN1856709A Method of predicting spot formation on the skin with the use of spot site-accelerating genes as indication and method of screening inhibitor for spot formation on the skin |
| 11/01/2006 | CN1856708A Human diabetes-mediating proteins |
| 11/01/2006 | CN1856580A Programmable molecular barcodes |
| 11/01/2006 | CN1856579A Methods of synthesizing polynucleotides using thermostable enzymes |
| 11/01/2006 | CN1856573A Microarray for assessing neuroblastoma prognosis and method of assessing neuroblastoma prognosis |
| 11/01/2006 | CN1856570A Method for diagnosis of tuberculosis by smear microscopy, culture and polymerase chain reaction using processed clinical samples and kit thereof |
| 11/01/2006 | CN1856505A Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| 11/01/2006 | CN1856504A Anti-infarction molecules |
| 11/01/2006 | CN1856503A Peptide originating in hepatitis c virus |
| 11/01/2006 | CN1854313A Method for diagnosing non-small cell lung cancers |
| 11/01/2006 | CN1854312A Comparation of expression account of the same gene in different original resources by base sequence determination |
| 11/01/2006 | CN1854311A Conditional touchdown multiplex polymerase chain reaction |
| 11/01/2006 | CN1854310A Geotype setting method |
| 11/01/2006 | CN1854309A Method of amplifying nucleic acid |